Milk-derived proteins and peptides in clinical trials
Clinical trials are reviewed, involving proteins and peptides derived from milk (predominantly bovine), with the exception of lactoferrin, which will be the subject of another article. The most explored milk fraction is α-lactalbumin (LA), which is often applied with glycomacropeptide (GMP) - a case...
Saved in:
Published in | Postȩpy higieny i medycyny doświadczalnej Vol. 67; pp. 800 - 816 |
---|---|
Main Authors | , |
Format | Journal Article |
Language | English |
Published |
Poland
06.08.2013
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Clinical trials are reviewed, involving proteins and peptides derived from milk (predominantly bovine), with the exception of lactoferrin, which will be the subject of another article. The most explored milk fraction is α-lactalbumin (LA), which is often applied with glycomacropeptide (GMP) - a casein degradation product. These milk constituents are used in health-promoting infant and adult formulae as well as in a modified form (HAMLET) to treat cancer. Lactoperoxidase (LCP) is used as an additive to mouth hygiene products and as a salivary substitute. Casein derivatives are applied, in addition, in the dry mouth syndrome. On the other hand, casein hydrolysates, containing active tripeptides, found application in hypertension and in type 2 diabetes. Lysozyme is routinely used for food conservation and in pharmaceutical products. It was successfully used in premature infants with concomitant diseases to improve health parameters. When used as prophylaxis in patients with scheduled surgery, it significantly reduced the incidence of hepatitis resulting from blood transfusion. Lysozyme was also used in infected children as an antimicrobial agent showing synergistic effects in combination with different antibiotics. Proline-rich polypeptide (PRP) was introduced to therapy of Alzheimer's disease patients. The therapeutic value of PRP was proved in several clinical trials and supported by studies on its mechanism of action. Concentrated immunoglobulin preparations from colostrum and milk of hyperimmunized cows showed efficacy in prevention of infections by bacteria, viruses and protozoa. A nutrition formula with milk-derived TGF-β2 (Modulen IBD®) found application in treatment of pediatric Crohn's disease. In conclusion, the preparations containing milk-derived products are safe and effective measures in prevention and treatment of infections as well as autoimmune and neoplastic diseases. |
---|---|
AbstractList | Clinical trials are reviewed, involving proteins and peptides derived from milk (predominantly bovine), with the exception of lactoferrin, which will be the subject of another article. The most explored milk fraction is α-lactalbumin (LA), which is often applied with glycomacropeptide (GMP) - a casein degradation product. These milk constituents are used in health-promoting infant and adult formulae as well as in a modified form (HAMLET) to treat cancer. Lactoperoxidase (LCP) is used as an additive to mouth hygiene products and as a salivary substitute. Casein derivatives are applied, in addition, in the dry mouth syndrome. On the other hand, casein hydrolysates, containing active tripeptides, found application in hypertension and in type 2 diabetes. Lysozyme is routinely used for food conservation and in pharmaceutical products. It was successfully used in premature infants with concomitant diseases to improve health parameters. When used as prophylaxis in patients with scheduled surgery, it significantly reduced the incidence of hepatitis resulting from blood transfusion. Lysozyme was also used in infected children as an antimicrobial agent showing synergistic effects in combination with different antibiotics. Proline-rich polypeptide (PRP) was introduced to therapy of Alzheimer's disease patients. The therapeutic value of PRP was proved in several clinical trials and supported by studies on its mechanism of action. Concentrated immunoglobulin preparations from colostrum and milk of hyperimmunized cows showed efficacy in prevention of infections by bacteria, viruses and protozoa. A nutrition formula with milk-derived TGF-β2 (Modulen IBD®) found application in treatment of pediatric Crohn's disease. In conclusion, the preparations containing milk-derived products are safe and effective measures in prevention and treatment of infections as well as autoimmune and neoplastic diseases. Clinical trials are reviewed, involving proteins and peptides derived from milk (predominantly bovine), with the exception of lactoferrin, which will be the subject of another article. The most explored milk fraction is α-lactalbumin (LA), which is often applied with glycomacropeptide (GMP) - a casein degradation product. These milk constituents are used in health-promoting infant and adult formulae as well as in a modified form (HAMLET) to treat cancer. Lactoperoxidase (LCP) is used as an additive to mouth hygiene products and as a salivary substitute. Casein derivatives are applied, in addition, in the dry mouth syndrome. On the other hand, casein hydrolysates, containing active tripeptides, found application in hypertension and in type 2 diabetes. Lysozyme is routinely used for food conservation and in pharmaceutical products. It was successfully used in premature infants with concomitant diseases to improve health parameters. When used as prophylaxis in patients with scheduled surgery, it significantly reduced the incidence of hepatitis resulting from blood transfusion. Lysozyme was also used in infected children as an antimicrobial agent showing synergistic effects in combination with different antibiotics. Proline-rich polypeptide (PRP) was introduced to therapy of Alzheimer's disease patients. The therapeutic value of PRP was proved in several clinical trials and supported by studies on its mechanism of action. Concentrated immunoglobulin preparations from colostrum and milk of hyperimmunized cows showed efficacy in prevention of infections by bacteria, viruses and protozoa. A nutrition formula with milk-derived TGF-β2 (Modulen IBD®) found application in treatment of pediatric Crohn's disease. In conclusion, the preparations containing milk-derived products are safe and effective measures in prevention and treatment of infections as well as autoimmune and neoplastic diseases.Clinical trials are reviewed, involving proteins and peptides derived from milk (predominantly bovine), with the exception of lactoferrin, which will be the subject of another article. The most explored milk fraction is α-lactalbumin (LA), which is often applied with glycomacropeptide (GMP) - a casein degradation product. These milk constituents are used in health-promoting infant and adult formulae as well as in a modified form (HAMLET) to treat cancer. Lactoperoxidase (LCP) is used as an additive to mouth hygiene products and as a salivary substitute. Casein derivatives are applied, in addition, in the dry mouth syndrome. On the other hand, casein hydrolysates, containing active tripeptides, found application in hypertension and in type 2 diabetes. Lysozyme is routinely used for food conservation and in pharmaceutical products. It was successfully used in premature infants with concomitant diseases to improve health parameters. When used as prophylaxis in patients with scheduled surgery, it significantly reduced the incidence of hepatitis resulting from blood transfusion. Lysozyme was also used in infected children as an antimicrobial agent showing synergistic effects in combination with different antibiotics. Proline-rich polypeptide (PRP) was introduced to therapy of Alzheimer's disease patients. The therapeutic value of PRP was proved in several clinical trials and supported by studies on its mechanism of action. Concentrated immunoglobulin preparations from colostrum and milk of hyperimmunized cows showed efficacy in prevention of infections by bacteria, viruses and protozoa. A nutrition formula with milk-derived TGF-β2 (Modulen IBD®) found application in treatment of pediatric Crohn's disease. In conclusion, the preparations containing milk-derived products are safe and effective measures in prevention and treatment of infections as well as autoimmune and neoplastic diseases. |
Author | Zimecki, Michał Artym, Jolanta |
Author_xml | – sequence: 1 givenname: Jolanta surname: Artym fullname: Artym, Jolanta – sequence: 2 givenname: Michał surname: Zimecki fullname: Zimecki, Michał |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/24018446$$D View this record in MEDLINE/PubMed |
BookMark | eNp1kE1LAzEQhoNUbK29e5I9etma2WSzyVGKVaHiRc9LNpmF6DZbk1Tw37ulrYjgXOaD5x1m3nMy8r1HQi6BzktB-Q1UrCiEYnOgAgQrT8hkN8p3s9GvekxmMb7RIbgSSsIZGRecguRcTEj55Lr33GJwn2izTegTOh8z7YcGN8lZjJnzmemcd0Z3WQpOd_GCnLZDwtkhT8nr8u5l8ZCvnu8fF7er3DAOKecVVA1rjFQNY4pLqwpZMFTWaBRYFRyQtZa1TQOVMSXoigK2tlGMVQVIy6bker93OOxjizHVaxcNdp322G9jDZyBgFJKGNCrA7pt1mjrTXBrHb7q46sDQPeACX2MAdsfBGi9M7Q-GlofDB0k4o_EuKST630K2nX_C78BPsZ2kA |
CitedBy_id | crossref_primary_10_1007_s12274_022_4385_4 crossref_primary_10_1016_j_ijbiomac_2020_07_224 crossref_primary_10_1155_2021_8822161 crossref_primary_10_1016_j_cofs_2017_03_003 crossref_primary_10_1111_jpn_13901 crossref_primary_10_1039_D0FO01447H crossref_primary_10_1016_j_anaerobe_2017_05_001 crossref_primary_10_1016_j_arcped_2018_02_006 crossref_primary_10_3945_an_114_007690 crossref_primary_10_1080_10408398_2021_1895063 crossref_primary_10_17135_jdhs_2024_24_4_231 crossref_primary_10_1093_advances_nmaa120 crossref_primary_10_31067_acusaglik_1273983 crossref_primary_10_3390_biomedicines11041015 crossref_primary_10_2174_1567201819666220513085552 crossref_primary_10_1093_nutrit_nuaa045 crossref_primary_10_1155_2020_2894169 crossref_primary_10_3390_nu9010015 crossref_primary_10_3389_fphar_2021_767642 crossref_primary_10_1038_s41598_017_16962_6 crossref_primary_10_1007_s00005_016_0392_z crossref_primary_10_3390_molecules27092941 crossref_primary_10_1590_fst_121122 crossref_primary_10_3390_nu10091332 crossref_primary_10_3389_fmicb_2022_1083432 crossref_primary_10_3390_app10207089 crossref_primary_10_1089_jmf_2019_0247 crossref_primary_10_1007_s11051_017_3782_1 crossref_primary_10_1016_j_fbio_2020_100771 crossref_primary_10_3390_life12040493 crossref_primary_10_1016_j_peptides_2015_08_009 crossref_primary_10_1080_20002297_2021_1879497 crossref_primary_10_1002_fsn3_2061 crossref_primary_10_2217_fvl_2020_0170 crossref_primary_10_3390_ijms241914730 crossref_primary_10_1007_s41061_017_0158_z crossref_primary_10_3390_nu8080446 crossref_primary_10_1007_s10989_023_10541_2 crossref_primary_10_1038_s41390_020_0961_z crossref_primary_10_1080_10408398_2023_2202254 crossref_primary_10_1016_j_jff_2015_06_021 crossref_primary_10_3390_pharmaceutics15041056 crossref_primary_10_3390_biomedicines11010114 |
ContentType | Journal Article |
DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 7X8 |
DOI | 10.5604/17322693.1061635 |
DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic |
DatabaseTitleList | MEDLINE MEDLINE - Academic |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1732-2693 |
EndPage | 816 |
ExternalDocumentID | 24018446 10_5604_17322693_1061635 |
Genre | Journal Article Review |
GroupedDBID | 2WC 3EA 5VS AAYXX ABDBF ABMXE ACUHS AENEX ALMA_UNASSIGNED_HOLDINGS CITATION DIK EBD EOJEC ESX F5P GX1 KQ8 MK0 OBODZ OK1 RNS TUS Y2W CGR CUY CVF ECM EIF NPM 7X8 |
ID | FETCH-LOGICAL-c341t-4717b3bc89b33948d92823e9dcae6e7241e3fd3fbb17cc51a701efdb9337218d3 |
ISSN | 1732-2693 |
IngestDate | Thu Jul 10 17:56:54 EDT 2025 Thu Apr 03 07:00:28 EDT 2025 Tue Jul 01 03:10:16 EDT 2025 Thu Apr 24 23:03:49 EDT 2025 |
IsDoiOpenAccess | false |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Language | English |
LinkModel | OpenURL |
MergedId | FETCHMERGED-LOGICAL-c341t-4717b3bc89b33948d92823e9dcae6e7241e3fd3fbb17cc51a701efdb9337218d3 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 ObjectType-Review-3 content type line 23 |
OpenAccessLink | http://publisherspanel.com/icid/pdf/1061635 |
PMID | 24018446 |
PQID | 1431615881 |
PQPubID | 23479 |
PageCount | 17 |
ParticipantIDs | proquest_miscellaneous_1431615881 pubmed_primary_24018446 crossref_primary_10_5604_17322693_1061635 crossref_citationtrail_10_5604_17322693_1061635 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2013-08-06 |
PublicationDateYYYYMMDD | 2013-08-06 |
PublicationDate_xml | – month: 08 year: 2013 text: 2013-08-06 day: 06 |
PublicationDecade | 2010 |
PublicationPlace | Poland |
PublicationPlace_xml | – name: Poland |
PublicationTitle | Postȩpy higieny i medycyny doświadczalnej |
PublicationTitleAlternate | Postepy Hig Med Dosw (Online) |
PublicationYear | 2013 |
SSID | ssj0000496981 |
Score | 2.1720364 |
SecondaryResourceType | review_article |
Snippet | Clinical trials are reviewed, involving proteins and peptides derived from milk (predominantly bovine), with the exception of lactoferrin, which will be the... |
SourceID | proquest pubmed crossref |
SourceType | Aggregation Database Index Database Enrichment Source |
StartPage | 800 |
SubjectTerms | Adult Alzheimer Disease - drug therapy Animals Anti-Bacterial Agents - pharmacology Anti-Infective Agents - pharmacology Antineoplastic Agents - therapeutic use Autoimmune Diseases - drug therapy Caseins - pharmacology Caseins - therapeutic use Cattle Clinical Trials as Topic Colostrum - chemistry Diabetes Mellitus, Type 2 - drug therapy Drug Synergism Food Preservation - methods Humans Hypertension - drug therapy Immunoglobulins - analysis Immunoglobulins - therapeutic use Infant Infant Food Infant, Premature, Diseases - drug therapy Infection Control - methods Lactalbumin - pharmacology Lactoperoxidase - pharmacology Milk - chemistry Milk Proteins - analysis Milk Proteins - pharmacology Milk Proteins - therapeutic use Neoplasms - drug therapy Peptide Fragments - pharmacology Xerostomia - drug therapy |
Title | Milk-derived proteins and peptides in clinical trials |
URI | https://www.ncbi.nlm.nih.gov/pubmed/24018446 https://www.proquest.com/docview/1431615881 |
Volume | 67 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1bb9MwFLZgkxAviDuDMQWJPqDJW1PnYj-2HdOEVJ42aeIl8pUFurRiGSj79Tu-pWUwBLxEURLbkT_n5Hy2z_kQeiszxUVGFS7ZCAgKMQxzrQWm8O9hqcnJ0AWFzT4WRyfZh9P8dKVP6KJLWrEnr34bV_I_qMI1wNVGyf4Dsn2lcAHOAV84AsJw_CuMZ_X8K1bQ0ndto_0XVrnS51xe2s0qym22WgU_OoWOi3V31Er1DqZ0MGbLbves_gzfebdb2wX3TnZwqhaDaT5gkx81V_KKzxv9ZTVC2s5HWAM5btreun-qz7X0WthuS76twAv_xMkFK_RA8TCkpvYGsSQjPCq8imG0mF5AI5g86jKN_mKKwZPK7KwAlLfF9yz1LHxmkjVklucOGnArgGlmN3Jiu79svHUXbY6ACYAp2xxPDiaH_UQaUJyC0dQvQdtW92-2aRM-h1p-9j5uoRTOtTh-iB4ETpCMPcCP0B3dPEb3ZmHXwxOUr-OcRJwTwDmJOCd1k0ScE4_zU3Ry-P54eoSD3AWW4Eq0GNyEUhAhKROEMPh-GNBhopmSXBe6BFdLE6OIESItpcxTXg5TbZRghACNp4o8QxvNotEvUJLC40LnMqdUZ9ykghtuFCPUOqjCpFtoP3ZDJUMueCtJMq-AE9o-rGIfVqEPt9C7vsTS50H5w7NvYs9WYKzsChRv9OLyAngmsQyDUniD577L-9oiRC9vvfMK3V-N0W200X671K_BJWzFThgU1_1MWbs |
linkProvider | EBSCOhost |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Milk-derived+proteins+and+peptides+in+clinical+trials&rft.jtitle=Post%C8%A9py+higieny+i+medycyny+do%C5%9Bwiadczalnej&rft.au=Artym%2C+Jolanta&rft.au=Zimecki%2C+Micha%C5%82&rft.date=2013-08-06&rft.eissn=1732-2693&rft.volume=67&rft.spage=800&rft_id=info:doi/10.5604%2F17322693.1061635&rft_id=info%3Apmid%2F24018446&rft.externalDocID=24018446 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1732-2693&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1732-2693&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1732-2693&client=summon |